Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.


BioAesthetics raises a $5M Series A to commercialize NACgraft, a regenerative nipple graft for breast cancer survivors; Period underwear company Thinx gets into activewear; Willow release their third generation breast pump at CES; Sextech company Lioness introduces a COVID Study and their recently launched sex research platform at CES; Gynesonics receives a $50M secured term loan from Runway Growth Capital for their intrauterine fibroid ablation system; Echo Health Ventures introduces a new Innovation Alliance; Porfolia’s Active Aging & Longevity Fund closes on Jan 31; The Digital Medicine Society (DiMe) announces the launch of IMPACT, a virtual-first medical practice collaborative; The New York Academy of Medicine launches a new initiative focused on maternal and child health; Bellabeat records 50.000+ preorders of its new wearable tracker Ivy within less than 1 month; Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer; Sera Prognostics partners with Anthem and HealthCore to improve outcomes for preterm babies; HealthLynked expands women’s healthcare services with the addition of new providers and updates to its Oohvie App & telemedicine services

You’ve found some of our exclusive Inner Circle Content.

This article is only available for our Inner Circle Members. To read on: